More Company News

Scancell

Six posters at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
26 Sep 2019Read More

Scancell

First collaboration agreement for its new platform technology, AvidiMab
04 Sep 2019Read More

Scancell

FY19 preliminary results
20 Aug 2019Read More

Scancell

SCIB1 study update
19 Aug 2019Read More

Scancell

H1 2019 business update
01 Jul 2019Read More

Scancell

Board appointment
18 Jun 2019Read More

Scancell

Share subscription and issue of equity to Vulpes Life Sciences Fund
13 Jun 2019Read More

Scancell

Update on SC1B2 development
20 May 2019Read More

Scancell

Establishment of Clinical Advisory Board and update on Modi1 progress
10 May 2019Read More

Scancell

UK regulatory approval to start SCIB1 Phase II advanced melanoma trial
25 Apr 2019Read More

1 2 3
Return to Scancell
© 2019 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).